-+ 0.00%
-+ 0.00%
-+ 0.00%

Quantum BioPharma To Broadcast Three-Part Series About Allegations Of Stock Market Manipulation Against Company

Benzinga·11/25/2025 21:02:46
Listen to the news

Quantum BioPharma Ltd. (NASDAQ:QNTM) (CSE:QNTM) (FRA: 0K91) ("Quantum BioPharma"), is pleased to announce that national television network CTV News' flagship investigative program W5 will air, starting today, a three-part series about Quantum Biopharma and the company's allegations of stock market manipulation.

Top CTV News journalist and W5 investigative reporter Jon Woodward describes Part One of the series in an article entitled, "Was a Canadian company's multiple sclerosis research nearly derailed by ‘market manipulation'?" The series explores the phenomenon of "stock spoofing," a market manipulation tactic that is illegal in both Canada and the United States, and the basis of a USD $700 million lawsuit by Quantum Biopharma against two of Canada's largest banks CIBC and RBC.